Youli Pan

SKLB1002, a Novel Potent Inhibitor of VEGF Receptor 2 Signaling, Inhibits Angiogenesis and Tumor Growth <i>In Vivo</i>

Shuang Zhang, Zhixing Cao, Hongwei Tian et al. · Clinical Cancer Research · 2011 · 101 citations

Discovery of Novel Pim-1 Kinase Inhibitors by a Hierarchical Multistage Virtual Screening Approach Based on SVM Model, Pharmacophore, and Molecular Docking

Ji-Xia Ren, Linli Li, Renlin Zheng et al. · Journal of Chemical Information and Modeling · 2011 · 72 citations

Medicinal Chemistry, Virtual Screening, Hit Identification +15

YLT192, a Novel, Orally Active Bioavailable Inhibitor of VEGFR2 Signaling with Potent Antiangiogenic Activity and Antitumor Efficacy in Preclinical Models

Yong Xia, Xuejiao Song, Deliang Li et al. · Scientific Reports · 2014 · 33 citations · Full text

A Preclinical Evaluation of SKLB261, a Multikinase Inhibitor of EGFR/Src/VEGFR2, as a Therapeutic Agent against Pancreatic Cancer

Youli Pan, Ming-Wu Zheng, Lei Zhong et al. · Molecular Cancer Therapeutics · 2014 · 30 citations

Combined SVM-based and docking-based virtual screening for retrieving novel inhibitors of c-Met

Qingqing Xie, Lei Zhong, Youli Pan et al. · European Journal of Medicinal Chemistry · 2011 · 26 citations · Full text

Chemical Biology, Molecular Docking, Medicinal Chemistry +12